Clinical Trial Update: HEALEY ALS Platform Trial - Regimen C CNM-Au8 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 HEALEY ALS Platform Trial evaluating Regimen C CNM-Au8 for amyotrophic lateral sclerosis has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CNM-Au8 (CNM-Au8)

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-25